Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 112701-112750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02616666
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
PHASE4Active, not recruiting
632 participants
Started: Aug 25, 2016 · Completed: Jul 31, 2026
1 condition3 sponsors132 locations
NCT02595892
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2Active, not recruiting
70 participants
Started: Aug 25, 2016 · Completed: Aug 5, 2026
4 conditions1 sponsor17 locations
NCT05995821
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
N/ARecruiting
1,250 participants
Started: Aug 25, 2016 · Completed: Aug 25, 2026
3 conditions2 sponsors1 location
NCT03158818
Chronic Hepatitis B Virus Infection in Zambia
N/AActive, not recruiting
326 participants
Started: Aug 23, 2016 · Completed: Jun 30, 2026
6 conditions3 sponsors1 location
NCT03143374
PET Tau - Neurodegenerative Disease Imaging
PHASE2/PHASE3Recruiting
300 participants
Started: Aug 23, 2016 · Completed: Sep 30, 2030
1 condition2 sponsors1 location
NCT02868268
Neuroblastoma Precision Trial
N/AActive, not recruiting
93 participants
Started: Aug 22, 2016 · Completed: Dec 31, 2025
1 condition6 sponsors11 locations
NCT03295773
Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography
N/ARecruiting
140 participants
Started: Aug 22, 2016 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT02845505
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
N/AActive, not recruiting
500 participants
Started: Aug 22, 2016 · Completed: Jun 30, 2026
1 condition2 sponsors12 locations
NCT02417662
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer
NAActive, not recruiting
340 participants
Started: Aug 19, 2016 · Completed: Aug 31, 2028
1 condition2 sponsors19 locations
NCT06426836
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NARecruiting
300 participants
Started: Aug 19, 2016 · Completed: Jul 1, 2026
9 conditions1 sponsor3 locations
NCT02734277
Type 1 Diabetes Extension Study
N/ARecruiting
111 participants
Started: Aug 18, 2016 · Completed: Mar 31, 2026
3 conditions2 sponsors12 locations
NCT02826434
Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
PHASE1Active, not recruiting
22 participants
Started: Aug 18, 2016 · Completed: Sep 30, 2027
1 condition3 sponsors5 locations
NCT02581930
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
PHASE2Active, not recruiting
18 participants
Started: Aug 17, 2016 · Completed: Mar 17, 2026
3 conditions1 sponsor13 locations
NCT02670525
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
NAActive, not recruiting
338 participants
Started: Aug 17, 2016 · Completed: Jan 31, 2028
2 conditions1 sponsor15 locations
NCT03345446
Circulating RNAs in Acute Congestive Heart Failure
N/AActive, not recruiting
200 participants
Started: Aug 17, 2016 · Completed: Dec 31, 2026
3 conditions5 sponsors3 locations
NCT02703207
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
NARecruiting
108 participants
Started: Aug 17, 2016 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03458936
Resilience in Adolescent Development
N/ARecruiting
1,500 participants
Started: Aug 17, 2016 · Completed: Dec 31, 2032
6 conditions1 sponsor1 location
NCT02872532
Testicular Tissue Cryopreservation in Children
NARecruiting
200 participants
Started: Aug 16, 2016 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03836521
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
N/ARecruiting
2,000 participants
Started: Aug 15, 2016 · Completed: Aug 15, 2028
1 condition1 sponsor1 location
NCT02721732
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
PHASE2Active, not recruiting
157 participants
Started: Aug 15, 2016 · Completed: Dec 31, 2025
19 conditions2 sponsors1 location
NCT04055753
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
N/AActive, not recruiting
24 participants
Started: Aug 12, 2016 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT03760835
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
PHASE4Recruiting
150 participants
Started: Aug 11, 2016 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT02700386
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
PHASE2Active, not recruiting
108 participants
Started: Aug 11, 2016 · Completed: Aug 31, 2025
1 condition1 sponsor3 locations
NCT02621151
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
PHASE2Active, not recruiting
60 participants
Started: Aug 11, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors5 locations
NCT04866251
Prevalence of Gag Reflex in Healthy Persons and Across Different Patient Groups and Its Relevance in Dysphagia Screening
NARecruiting
700 participants
Started: Aug 10, 2016 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT02821806
Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
N/ARecruiting
500 participants
Started: Aug 8, 2016 · Completed: Feb 1, 2035
1 condition1 sponsor1 location
NCT03822741
Etiology and Treatment of Neonatal Seizure
N/ARecruiting
2,000 participants
Started: Aug 8, 2016 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT03931707
The China Neonatal Genomes Project
N/ARecruiting
100,000 participants
Started: Aug 8, 2016 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT02312089
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
PHASE4Recruiting
200 participants
Started: Aug 7, 2016 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT02697227
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
NAActive, not recruiting
85 participants
Started: Aug 5, 2016 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT02861417
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
PHASE2Active, not recruiting
204 participants
Started: Aug 5, 2016 · Completed: Aug 31, 2026
14 conditions2 sponsors1 location
NCT02978521
Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients
NARecruiting
94 participants
Started: Aug 5, 2016 · Completed: Dec 12, 2025
3 conditions1 sponsor1 location
NCT03039309
Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom
N/ARecruiting
500 participants
Started: Aug 5, 2016 · Completed: Aug 4, 2028
1 condition1 sponsor1 location
NCT06935071
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
N/AActive, not recruiting
300 participants
Started: Aug 4, 2016 · Completed: Aug 4, 2026
4 conditions1 sponsor1 location
NCT02584244
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
PHASE1/PHASE2Recruiting
66 participants
Started: Aug 4, 2016 · Completed: Apr 30, 2026
4 conditions2 sponsors1 location
NCT02621398
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
23 participants
Started: Aug 4, 2016 · Completed: Dec 30, 2042
3 conditions4 sponsors3 locations
NCT02813135
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
PHASE1/PHASE2Recruiting
455 participants
Started: Aug 3, 2016 · Completed: Feb 28, 2031
1 condition2 sponsors21 locations
NCT02821767
Natural History, Pathogenesis, and Outcome of Ocular Disorders
N/ARecruiting
1,000 participants
Started: Aug 3, 2016 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT02864485
Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
NARecruiting
20 participants
Started: Aug 3, 2016 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT04639336
Cognitive and Neurological Pathologies in Pompe Disease
N/ARecruiting
45 participants
Started: Aug 3, 2016 · Completed: Mar 31, 2029
1 condition2 sponsors1 location
NCT02838420
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
187 participants
Started: Aug 3, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor21 locations
NCT02818517
Evaluation and Management of Cardio Toxicity in Oncologic Patients
N/ARecruiting
1,000 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT03534050
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
PHASE2/PHASE3Recruiting
80 participants
Started: Aug 1, 2016 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT02863757
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
N/ARecruiting
1,500 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03737799
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With Diabetes
N/AActive, not recruiting
1,815 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2024
1 condition4 sponsors1 location
NCT02914483
Women's Heart Attack Research Program: Stress Ancillary Study
NARecruiting
200 participants
Started: Aug 1, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor14 locations
NCT02847559
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
PHASE2Recruiting
27 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2026
6 conditions3 sponsors8 locations
NCT05945407
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
NARecruiting
57 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2027
5 conditions10 sponsors1 location
NCT03243448
Skin Sympathetic Nerve Activity and Sympathetic Tone
N/AEnrolling by invitation
1,000 participants
Started: Aug 1, 2016 · Completed: Jul 31, 2026
2 conditions1 sponsor0 locations
NCT04147806
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer
PHASE2Active, not recruiting
30 participants
Started: Aug 1, 2016 · Completed: Jul 13, 2026
1 condition1 sponsor1 location